Abstract
Blind subterranean mole rats retain a degenerated, subcutaneous, visually blind but functionally circadian eye involved in photoperiodic perception. Here we describe the cloning, sequence, and expression of the circadian Clock and MOP3 cDNAs of the Spalax ehrenbergi superspecies in Israel. Both genes are relatively conserved, although characterized by a significant number of amino acid substitutions. The glutamine-rich area of Clock, which is assumed to function in circadian rhythmicity, is expanded in Spalax compared with that of humans and mice, and is different in amino acid composition from that of rats. We also show that MOP3 is a bona fide partner of Spalax Clock and that the Spalax Clock/MOP3 dimer is less potent than its human counterpart in driving transcription. We suggest that this reduction in transcriptional activity may be attributed to the Spalax Clock glutamine-rich domain, which is unique in its amino acid composition compared with other studied mammalian species. Understanding Clock/MOP3 function could highlight circadian mechanisms in blind mammals and their unique pattern as a result of adapting to life underground.
Biological Clocks Underground
The behavior of all eukaryotic organisms is characterized by a 24-h cycle of rest and activity, as a fundamental adaptation to the solar cycle of light and darkness (1–4). In mammals, the pacemaker of this circadian rhythm is localized in the central nervous system (5) and it is entrained by light signals in the eye. An intriguing question is how a subterranean, naturally blind mammal with a subcutaneous degenerated eye maintains its circadian system, and whether its examination can illuminate circadian rhythmicity of sighted mammals above ground.
The underground adaptive ecogeographical radiation of the Spalax ehrenbergi superspecies in Israel involves four sibling species: Spalax galili, Spalax golani, Spalax carmeli, and Spalax judaei, with diploid chromosome numbers 2n = 52, 54, 58, and 60, respectively (6), displaying progressive stages of final ecological speciation (7, 8). Their adaptive radiation in Israel, from early Pleistocene to Recent times, is closely associated with increasing aridity stress, hence, with distinct climatic diversity. S. galili, radiated in the cool-humid northern upper Galilee Mountains; S. golani, in the cool-semidry northeastern Golan Heights; S. carmeli, in warm-humid central Israel; and S. judaei, in warm-dry southern Samaria, Judea, and the northern Negev mountains and plains.
Spalax represents an extreme example of natural eye and brain reorganization in mammals (8, 9). The animal is completely blind (10), yet the retina of the atrophied subcutaneous eye functions in photoentrainment of locomotor activity and thermoregulatory rhythms (11–13). Ocular regression of thalamic sight structures conceals adaptive progression of the photoperiodic system (14, 15). Retinal rhodopsin (16) and coneopsin participate in photoentrainment (17, 18). Per-homologous ACNGGN sequence comprising poly(Thr-Gly) shows hypothalamic circadian oscillation (19). Thus, Spalax displays behavioral circadian rhythm adapted to life underground.
Activity patterns were tested in the four sibling species of the S. ehrenbergi superspecies (20). Activity patterns were found to be polyphasic and polymorphic (19, 20), with a remarkable intra- and interspecies diversity in circadian patterns (refs. 21 and 22—no species is identified in the latter study) coupled with seasonal shifts.§ This complex pattern is unique in mammals analyzed to date. These patterns may display an adaptive strategy of a subterranean mammal, safeguarded from above-ground predation.
Molecular Genetic Basis of Circadian Rhythms
In recent years, tremendous progress has been achieved in revealing the molecular-genetic basis of circadian activity in different organisms across phylogeny, including cyanobacteria, plants, fungi, insects, and mammals (1, 23). All show homologous circadian molecules, both structurally and functionally (23). The circadian genes identified in mammals are Clock, MOP3, Per1, Per2, Per3, Tim, Cry1, and Cry2 (23), all interacting in circadian rhythmicity. In Drosophila, the sex-linked period (Per) gene affects rhythmicity in circadian (24-h), ultradian (<24-h), and infradian (>24-h) time domains (24). Work in Drosophila and mice suggested a mechanism in which expression of Per genes is driven by a CLOCK/MOP3 heterodimer, which, through their basic helix–loop–helix (bHLH) motif and the PAS domains, binds to the E-box present in the Per promoter, thereby activating Per transcription. PER/TIM and PER/CRY complexes probably block the activation of Per transcription by interfering with the activity of Clock/MOP3 (25). Indeed, it was recently proven (26) that the loss of PAS protein MOP3 in mice results in immediate and complete loss of circadian rhythmicity. Recent studies (27) more specifically clarify the detailed mechanism of the regulation of the circadian rhythm. Studying mutant Clock, Per2, and Cry of mice, Shearman et al. (27) showed that Per2 has a dominant role in the positive regulation of the MOP3, whereas the Crys are the negative regulators of the Per and Cry cycles. Clock mutants appear to positively alter the regulation of MOP3 gene expression in the suprachiasmatic nucleus (SCN), but not the regulation of Clock itself. As the oscillations of the Pers and Crys RNA are down-regulated in the Clock mutant mice, the effect of Clock on MOP3 levels is probably indirect and may occur through the Pers and/or the Crys proteins; the reduced levels of one or more of these genes may cause the reduced levels of MOP3 in the Clock mutant mice through loss of the positive control of MOP3 transcription.
The underlying genetic basis of circadian rhythms in the blind, subterranean mole rats may be different from that of strictly diurnal or nocturnal and sighted mammals, such as humans and mice, which presumably lack multiphasic, polymorphic, and seasonal biological circadian patterns. The coupled ecological and phylogenetic uniqueness of Spalax makes it an intriguing model organism for assessing the molecular-genetic machinery of the biological clock.
Our objectives in this study were to compare and contrast the structure and the expression of the Clock gene in the blind subterranean mole rat with those of other mammals, and suggest experiments for its potential effects on the unique circadian rhythmicity of these species. We show differences in Clock structure and expression between mole rats, rats, mice, and humans. We also demonstrate differences among three mole rat species whose significance may derive from the ecological differences of the species—a testable hypothesis.
Materials and Methods
Animals.
Animals used for the cloning of the mole rat Clock belong to three species of the S. ehrenbergi superspecies in Israel (6–8). The species name is followed by the diploid chromosome number, population name, and the geographic region: S. galili, 2n = 52, Kerem Ben Zimra, Upper Galilee; S. carmeli, 2n = 58, Muhraka, Mt. Carmel; S. judaei, 2n = 60, Anza, Samaria. The S. galili was also used for the cloning of MOP3. All of the animals used in these experiments were captured in the field and kept in our animal facility for at least 3 months before use. Animals were housed in individual cages, each species in a separate room. They were kept under controlled conditions of 22–24°C with seasonal light/dark hours and fed with carrots and apples. Animals used in this study were adults and of similar weight (100–150 g).
Cloning.
By reverse transcriptase (RT)-PCR (28), we cloned the complete ORF of Clock from three individuals each belonging to a different species as described above. The oligonucleotides used for the RT-PCR cloning were designed according to the published sequence of human Clock (GenBank accession no. AF011568) and that of the mouse (GenBank accession no. AF000998). These were a 5′ sense oligonucleotide 5′-ACAAGACGAAAAC(GA)TA(GA)T(AG)TGTTATG (the 3′ ATG is the initiation codon), and a 3′ antisense oligonucleotide 5′-AGAGAGGAAG(CT)(AG)(CT)GTGTGCTA (the 3′ CTA is the termination codon).
To construct the S. galili Clock cDNA with a replaced human Q-rich (glutamine-rich) domain (sClock-hQ) and the human equivalent (hClock-sQ), Clock cDNA fragments from both species, equivalent to Spalax amino acids numbers 1–744 and 736–865 (see GenBank accession no. AJ318057) were amplified and joined by PCR.
Spalax MOP3 cDNA was also cloned by RT-PCR from S. galili brain tissue by using oligonucleotides designed according to the published sequence of human MOP3 (GenBank accession no. AF044288) and that of the mouse (GenBank accession no. AB015203). These were a 5′ sense oligonucleotide 5′-TG(T/C)(G/A)A(C/G)(T/C)(T/A)C(A/C)G(A/T)(T/C)C(A/T)TCCAATG (the 3′ ATG is the initiation codon) and a 3′ antisense oligonucleotide 5′GCCAAAGCAACATGTAGTGT(T/C)(T/C)A. The (T/C)(T/C)A is a combination of the three possible termination codons. The tissues used in this study for the RT-PCR experiments were collected at the same time from all individuals.
Similarity Tree.
The tree presented is a protein (amino acids)-based tree using Kimura's protein distance (29). The tree is derived by using the Wisconsin package version 10 (Genetics Computer Group, Madison, WI), using the neighbor-joining method. We chose this method after Weir (30), who summarized the simulation studies and showed that this method is among the best methods based on distance matrices.
Transcriptional Activity.
The entire ORFs of Spalax (s) and human (h) Clock as well as sClock-hQ and hClock-sQ were cloned into the pTARGET expression vector (Promega). Plasmids expressing these constructs were cotransfected with an hMOP3 or sMOP3-expressing plasmid and the M34RE-luciferase reporter plasmid into the human hepatoma cell line Hep3b. The M34RE-luciferase has three E-box elements (the CACGTG sequence), a transcription factor-binding site found in the Per1 promoter region, in tandem upstream of the luciferase gene (25). Transfections were performed by means of Lipofectamine (Life Technologies). In all experiments, the luciferase reporter activity was normalized to β-galactosidase expression resulting from cotransfection of a control plasmid [a cytomegalovirus (CMV) promoter that drives the expression of the β-galactosidase gene]. Cells were incubated for 20 h before harvest. The luciferase activity was determined as described (25). The relative light units (RLUs) were calculated from the luciferase activity divided by the β-galactosidase activity for each assay.
In Situ Hybridization.
Animals used for testing the brains were kept in a controlled environment of 12-h light/12-h dark. All specimens came from diurnal animals, as was proven by monitoring their locomotor activity. Spalax brains were removed under sterile conditions at Zeitgeber times ZT0, ZT6, ZT12, and ZT18 (ZT0 is when lights are turned on, and ZT12 is when lights are turned off) and fixed in ice-cold 4% paraformaldehyde/PBS for 16–20 h. Tissues were dehydrated, embedded in paraffin, and sectioned at a thickness of 10 μm. In situ hybridization was performed as described (31). The Clock probes corresponded to nucleotides 423-1290 of Spalax cDNA (amino acids 141–430 in accession no. AJ318057) and the MOP3 probes to nucleotides 1–864 of Spalax cDNA (amino acids 1–288 in accession no. AJ318060). Antisense and sense riboprobes were synthesized with T3 or T7 RNA polymerase in the presence of 5′-α35S-UTP (1,250 Ci/mmol; 1 Ci = 37 GBq; DuPont/NEN). Hybridization was done overnight at 55°C. Stringency washes were performed at 64°C. Slides were dipped in NTP-2 emulsion and exposed for 6 days. Tissue was visualized by fluorescence of Hoechst dye 33258-stained nuclei (blue color in figure). Silver grains were visualized by dark-field illumination. Image is a videograph captured with ADOBE PHOTOSHOP. Experiments were performed in duplicate.
Results
Spalax Clock and MOP3 cDNA Structure.
A full length Spalax cDNA for Clock was isolated from three of the Israeli species, namely S. galili, S. carmeli, and S. judaei. A full-length cDNA of Spalax MOP3 was isolated from S. galili. The clones were obtained by RT-PCR of brain tissue by using oligonucleotides from the translational initiation and termination sites of the previously published human and mouse counterparts.
The Spalax Clock cDNA is over 90% similar to the genes of mice, rats (accession no. NM021856), and humans (for the complete cDNA sequences and the deduced amino acids of the three Spalax species see accession nos. AJ318057, AJ318058, and AJ318059). Translated, however, Spalax Clock cDNA encodes a protein of 865 aa compared with 855 in mice, 846 in humans, and 862 in rats (32). The Gly-Met-Asn-Thr at positions 610–613 in human, missing in mouse, occur in the three Spalax species, though Thr is replaced by Ala in all Spalax species. Glutamine at position 629 in mice is missing in humans, and occurs in all Spalax species. Table 1 summarizes the synonymous and nonsynonymous mutations among the three Spalax species studied and then between them and humans and mice. Spalax has 18–26 amino acid substitutions compared with humans, and 35–42 substitutions compared with mice. S. judaei (S60) and S. carmeli (S58), geographically adjacent species, differ in 8 amino acids and 12 mutations. S. judaei differs from the more northern species, S. galili (S52), in 10 amino acids and in a total of 13 mutations. S. galili and S. carmeli, which are geographical neighbors, differ in 3 amino acids and 7 mutations. The bHLH domain and the two PAS domains of Clock cDNA are similar in all studied species. The most impressive difference between Spalax and humans and mice is in the Q-rich domain as can be seen in Fig. 1. The Spalax repeat is 18 aa longer than that found in humans and 5 aa longer than that of mice and it is different in amino acid composition from rats.
Table 1.
S52 | S58 | S60 | Mus | Hu | |
---|---|---|---|---|---|
S52 | — | ||||
S58 | 3ns + 4s (7) | — | |||
S60 | 10ns + 3s (13) | 8ns + 4s (12) | — | ||
Mus | 37ns + 148s (185) | 35ns + 150s (185) | 42ns + 151s (193) | — | |
Hu | 18ns + 154s (172) | 26ns + 147s (173) | 26ns + 152s (178) | 25ns + 193s (218) | — |
The distances in Clock cDNA sequence among the three Spalax species studied (S52, S58, and S60), mouse (Mus), and humans (Hu). The distance is expressed in number of synonymous (s) and nonsynonymous (ns) substitutions. The total number of substitutions appears in parentheses. Note the larger number of substitutions between Spalax and humans than that between Spalax and mouse. Also noteworthy is the unusual larger number of nonsynonymous mutations compared with the synonymous substitutions among the Spalax species, indicating interspecies functional changes.
The S. galili MOP3 cDNA (accession no. AJ318060) is also very similar to those of mouse and human. The putative peptide encodes 626 amino acids. Like human MOP3 (accession no. AF044288), it misses the Leu-Asp-Asp-Phe-Ala-Phe-Glu, which appears in the mouse (position 48 to 54 in the mouse peptide, accession no. AB015203). There are 8 unique amino acid substitutions in the Spalax peptide (positions 304, 306, 330, 332, 334, 338, 476, and 580). However, the activity domains bHLH and PAS are completely identical in the three species.
The Clock Similarity Trees.
We have used the Kimura distances (30) to generate two trees. One is based on the distances between nucleic acids and the other is based on distances between amino acids (Fig. 2). The method examines each pair of aligned sequences item by item and counts the number of exact matches, partial matches, and gap symbols. If the sequences are nucleic acids, transitions and transversions are also tallied. The Clock similarity trees show that S. judaei, the youngest species, seems to evolve faster than its older sibling species. Furthermore, Spalax is somewhat closer to humans than to mice in CLOCK protein structure (see also Table 1). This result is in contrast with all other phylogenetic trees of Spalax derived from other sets of data (6–8).
Function of the Clock/MOP3 Dimer.
As already stated above, Spalax has a distinctly different polyglutamine (polyQ) repeat (Fig. 1). The Spalax MOP3 is very similar to the human MOP3 repeat, but also to the mouse protein. To functionally test whether the difference in the Q-repeat affects Spalax Clock activity, we compared S. galili Clock with human Clock, which is shorter by 18 aa at the polyQ domain. This was done by an assay that measures transactivation by Clock/MOP3 heterodimer of E-box elements, a type of transcription factor-binding site found adjacent to Per1 and important for Per1 expression (25). We found that Spalax Clock is a bona fide partner of MOP3 as shown by this E-box/luciferase reporter assay. Note too that its activity is only 30%, hence, it is significantly lower (P < 0.001) compared with human protein (Fig. 3). Dimerizing human or Spalax Clock with human or Spalax MOP3 does not influence their relative activity. However, replacing the Q-rich domain between the two species does invert their relative activity. That is to say, that hClock-sQ as a dimer of either hMOP3 or sMOP3 is as active as sClock, and sClock-hQ as a dimer of either hMOP3 or sMOP3 is as active as hClock (Fig. 3).
The Expression of Spalax Clock and MOP3.
In situ hybridization localizes Spalax Clock and MOP3 expression to the SCN in the brain (Fig. 4), the center of the mammalian circadian clock (5). Spalax Clock does not oscillate, but its MOP3 does oscillate, which is similar to what is found in other species studied (23). Furthermore, RT-PCR demonstrates (Fig. 5) that Spalax Clock is expressed in several different organs, i.e., in the brain, retina, and harderian gland, as well as in the peripheral tissues kidney and liver. MOP3 is expressed in all tissues studied. Its expression is quite low in kidney and spleen; however, like Clock, it is expressed in those tissues that are involved in the maintenance of the circadian system, namely brain, eye, and harderian gland. As demonstrated in Fig. 6, MOP3 also oscillates in the harderian gland, and although its oscillatory pattern is different from its pattern in the SCN, the peak of its expression is identical in both tissues.
Discussion
Circadian rhythm is localized in the central nervous system and is entrained by light signals in the eye. Lightless habitats lead to structural regressive eye evolution (8). Is function also lost? Maintenance of eye rudiments after millions of years in darkness suggests functionality. Blind subterranean mole rats, S. ehrenbergi superspecies (Spalacidae, Rodentia) in Israel, have undergone evolutionary tinkering that has optimized molecular and structural reductions and expansions presumably through loss-and-gain of homeotic mutations in organizing a photoperiodic system, adapting to life in total darkness underground (8). In our current work we present data on the cloning, structure, and expression of circadian genes from a visually blind, subterranean mammal.
Spalax Clock and MOP3 Structure.
Despite being a rodent, Spalax, an old rodent offshoot (7, 8), is somewhat closer to humans than to mice in Clock structure, as was already manifested for some other genes, i.e., Mhc loci (33), VEGF cDNA (34), and HMG1 genes (preliminary results). Spalax presumably still retains early rodent patterns reorganized and adapted to life underground. Spalax Clock demonstrates distinct interspecies polymorphism and S. judaei, the youngest species of the Spalax ehrenbergi superspecies in Israel (6, 7), seems to evolve faster than the relatively older S. galili and S. carmeli species, suggesting distinct interspecies divergence across very short geographic distance (≈80 km). This may be due to its unique xeric ecology with large territories and its polyphasic activity pattern in a stressful climate (6–8). Note that already in our first study of activity patterns of different S. ehrenbergi species (20), we found that S. judaei, which inhabits a significantly warmer and drier environment than the northern species, S. galili and S. carmeli, has a significantly different activity profile in both levels and patterns. S. judaei is less active and has more, albeit shorter, periods of activity, displaying an adaptive strategy of increasing fitness in xeric environments (20).
Evolution of the Clock Gene in Spalax Species.
The phylogenetic relationship of the four Spalax species was analyzed earlier by allozymes (35), mtDNA (36, 37), and DNA–DNA hybridization (38). The tree presented here displaying the interspecies Clock similarity relationship of the three Spalax species is different from the phylogenetic trees derived from allozymes, mtDNA, and DNA–DNA hybridization. Like the tree derived from cytochrome b (39), the Clock tree seems to represent not chronological relationships, but a gene tree that describes the rate of ecological evolution of the Clock gene in different species. This assumption is supported by the comparison between silent and nonsilent substitutions presented in Table 1. This table shows that the distances with human and mouse Clock involves 3 to 7 times more silent substitutions than nonsilent mutations, which is the usual result when comparing sequences. However, a comparison of the three Spalax species exhibits 2 to 3 times more substitutions that cause amino acid changes than those that are synonymous. This is a very unusual observation in phylogenetic trees. The dramatic divergence of the youngest species, S. judaei, which displays much faster evolution (more amino acid changes) cannot be reconciled with its relatively recent divergence (6–8, 40). It appears more plausible that ecological factors were involved, such as spatiotemporal increasing stressful aridity, which may indirectly affect the circadian pattern, as was demonstrated by radiotracking in time.§
Expression and Function of the Clock/MOP3 Dimer.
Circadian oscillators appear to be highly conserved throughout evolution and involve transcription-translation negative feedback loops (3, 23). The observation that PAS proteins play an important role in maintaining circadian rhythms supports this idea (41, 42). A distinguishing characteristic of the Clock gene is the presence of several functional domains in its amino acid sequence. These are the bHLH (amino acids 34–81), the PAS A direct repeat (amino acids 115–163), the PAS B direct repeat (amino acids 272–318), and the Q-rich domain at the C terminus. Although the bHLH and PAS domains are very conserved among the different Clock cDNAs that have been cloned, the most striking difference is in the significant variation in the Q-repeat near the C terminus of Clock. The Q-repeat characterizes the activation domains of many transcription factors (43), and it has been shown to influence circadian rhythmicity (44). It has been shown that A → T nucleotide transversion in a splice donor site, which results in exon skipping and a deletion of 51 aa from the Q-repeat area in the mouse protein, appears to be the cause of a number of changes in the circadian phenotype (45). Most notably, mice homozygous for this deletion manifest a 3–4 h longer period (27–28 h) on initial placement in the dark and then become arrhythmic after a few weeks in darkness. A 6-h exposure to light of these arrhythmic mice restores the long-period rhythmicity. Hence, in addition to a bHLH region (DNA binding domain) and PAS region (protein dimerization domain) Clock also contains a transcriptional activation domain (the Q-rich region). The mutant protein can therefore compete with nonmutant Clock for binding partners and/or DNA binding sites, which explains the dominant negative nature of the mutant allele (44).
Evidence demonstrates that proper activity of the circadian system requires heterodimerization of two bHLH-PAS proteins: Clock and MOP3 (25, 26, 46). Our results prove that there is a reduced transcriptional activity (P < 0.001) of the Spalax Clock/MOP3 dimer compared with humans, possibly increasing metabolic economy (15). The fact that this pattern is retained after interchanging the Q-rich domains of the two species supports an assumption that it is this domain that causes the difference in transcriptional activity. It was already shown that mutant Clock could form heterodimers with MOP3 that bound DNA but failed to activate transcription (46). Moreover, such a mutant, probably by down-regulating the oscillations of Pers and Crys RNA, leads to reduced levels of MOP3 transcription, hence limiting the available Clock/MOP3 heterodimers at the appropriate circadian time to drive Per/Cry transcription and restart the cycle (27). This suggests that Clock, after binding to a specific transcription activation site (the E-box), upstream the initiation site of Per, appears to drive the positive component of Per transcriptional oscillations, which are thought to underlie circadian rhythmicity. Thus, the Spalax-unique Clock may partially inactivate transcription, while retaining the ability to bind DNA and dimerize with partners. Further studies are essential to directly relate the unique polyQ repeat of Spalax Clock, with the reduced transactivation by Spalax Clock or with its unique polytypic (20), polymorphic (19), and seasonal§ differences in circadian rhythms. Nevertheless, other differences in the Spalax Clock or MOP3 sequence, although evolutionarily impressive, cannot be related to any presently known functional sites. Hence, the reduced activity of Spalax Clock may be cautiously attributed to the different polyQ of its protein. Transgenic mice with Spalax Clock may elucidate its direct function.
Tissue Distribution and Oscillation of Spalax Clock and MOP3 Expression.
As in other mammals, Spalax Clock does not oscillate, but Spalax MOP3 does oscillate (23). Notably, the oscillatory pattern of MOP3 in the Spalax SCN is a mirror image of that of the mouse Per1 (32) as well as the Spalax equivalent (preliminary results). That is, MOP3 expression is at its minimum at ZT6, when Per1 expression is at its maximum. This observation may be explained by Shearman's et al. (27) interpretation of the feedback mechanism between Clock/MOP3 heterodimer level and the transcription drive of Per/Cry.
The tissue distribution of Spalax Clock is not restricted to tissues directly related to the maintenance of the biological clock, as was reported in mice (44). It may be involved, as was shown in Drosophila, in both circadian (47) and noncircadian oscillations in nonpacemaker tissues (48), or as hypothesized by Yamazaki et al. (49) in transgenic rats, that a self-sustained circadian pacemaker in the SCN entrains circadian oscillations in the peripheral tissues. MOP3 is expressed in all tissues studied, which is similar to what was demonstrated in mice and may reflect its involvement as an orphan dimerizing protein in other transcription activation systems, like the hypoxia-inducible factor (25).
Clock and MOP3 Expression in the Harderian Gland.
We are aware of no other report of expression of circadian genes in the harderian gland. Although the oscillatory pattern of MOP3 is different from its pattern in the SCN, the peak of its expression is identical in both tissues. This may indicate a unique synchronization of these two tissues that has yet to be clarified, because in other tissues there is always a lag in the peak of expression of oscillatory circadian genes between the SCN and peripheral tissues. The expression of Clock and MOP3 in the harderian gland of Spalax is remarkable and should be emphasized: the harderian gland of Spalax is tremendously hypertrophied, occupying the entire eye-socket, whereas the eye is degenerated (0.7 mm in diameter), subcutaneous, and embedded in that huge harderian gland. It was previously suggested that the harderian gland of Spalax is a possible photoreceptor and photoperiodic organ (11).
Circadian Genes in a Blind Subterranean Mammal.
Expression of circadian genes in blind Spalax may highlight the genetic basis of its behavioral pattern of circadian rhythmicity (19–22). We have already cloned the Spalax cDNA homologs of Per1, Per2, Per3, Tim, Cry1, and Cry2 (unpublished results). We plan to evaluate their function and their potential convergence in other subterranean mammals. Likewise, the Spalax photoreceptor pigment rhodopsin (16) and long-wavelength coneopsin (17, 18, 50) have been cloned and sequenced, and their unique Spalax function in photoentrainment was evaluated, presumably as adaptations to life underground by significant enrichment for wavelengths greater than 500 nm, maximizing photon capture, but minimizing the effects of heat (18).
The mosaic evolution of the Spalax eye (7, 14, 15), harderian gland (51), and brain (52), and its circadian genes provides a dramatic model of tinkering evolution at both the molecular and organismal levels. From an evolutionary perspective, the genetic basis of circadian rhythms in blind subterranean mole rats may be different from that of strictly diurnal or nocturnal and sighted mammals. The identification of the blind Spalax Clock might help, together with its other circadian genes, highlighting the structure and evolution of the circadian organization in mammals, including humans, at the molecular level and their ecological causation. Furthermore, it may highlight both adaptive evolution linking structure and function and behavioral–molecular interactions of regression, progression, and convergence in subterranean mammals generally, and especially in the Pleistocene ecological speciation of the Spalax ehrenbergi superspecies caused by increasing ecological aridity stresses (6–8), which in turn affect the patterns of circadian rhythmicity. It could also elucidate, by transgenic studies in mice, the control of the Spalax-unique polyphasic, polymorphic, and seasonal cycles, as well as sleeping disorders, work shifts, and jetlag in humans.
Acknowledgments
We thank Dr. J. Takahashi for the mouse Clock probe and Dr. C. Bradfield for his experimental help and advice with the transcriptional activation assay. We are also grateful to Mr. Michael Margulis for his help with the computer graphic work. This work was supported by a grant from Human Frontier Science Program and by the Ancell–Teicher Research Foundation for Genetics and Molecular Evolution.
Abbreviations
- RT
reverse transcriptase
- bHLH
basic helix–loop–helix
- SCN
suprachiasmatic nucleus
- RLU
relative light unit
- polyQ
polyglutamine
- hClock
human Clock
- sClock
Spalax Clock
Footnotes
References
- 1.Feldman J F. Annu Rev Plant Physiol. 1982;33:583–608. [Google Scholar]
- 2.Edmunds L N., Jr . Cellular and Molecular Bases of Biological Clocks: Models and Mechanisms for Circadian Timekeeping. New York: Springer; 1988. [Google Scholar]
- 3.King D P, Takahashi J S. Annu Rev Neurosci. 2000;23:713–742. doi: 10.1146/annurev.neuro.23.1.713. [DOI] [PubMed] [Google Scholar]
- 4.Wager-Smith K, Kay S A. Nature (London) 2000;26:23–27. doi: 10.1038/79134. [DOI] [PubMed] [Google Scholar]
- 5.Ralph M R, Foster R G, David F C, Menaker M. Science. 1990;247:975–978. doi: 10.1126/science.2305266. [DOI] [PubMed] [Google Scholar]
- 6.Nevo E, Ivanitskaya E, Beiles A. Adaptive Radiation of Blind Subterranean Mole Rats. Leiden, The Netherlands: Backhuys; 2001. [Google Scholar]
- 7.Nevo E. Evol Biol. 1991;25:1–125. [Google Scholar]
- 8.Nevo E. Mosaic Evolution of Subterranean Mammals: Regression, Progression, and Global Convergence. Oxford: Oxford Univ. Press; 1999. [Google Scholar]
- 9.Nevo E. In: Principles of Animal Design: The Optimization and Symmorphosis Debate. Weibel E R, Taylor C R, Bolis C, editors. Cambridge, U.K.: Cambridge Univ. Press; 1998. pp. 288–298. [Google Scholar]
- 10.Haim A, Heth G, Pratt H, Nevo E. J Exp Biol. 1983;107:59–64. doi: 10.1242/jeb.107.1.59. [DOI] [PubMed] [Google Scholar]
- 11.Pevet P, Heth G, Haim A, Nevo E. J Exp Zool. 1984;232:41–50. doi: 10.1002/jez.1402320106. [DOI] [PubMed] [Google Scholar]
- 12.Rado R, Gev H, Goldman B D, Terkel J. In: Photobiology. Riklis E, editor. New York: Plenum Press; 1991. pp. 323–331. [Google Scholar]
- 13.Sanyal S, Jansen H G, de Grip W G, Nevo E, de Jong W W. Invest Ophthalmol Visual Sci. 1990;31:1398–1404. [PubMed] [Google Scholar]
- 14.Cooper H M, Herbin M, Nevo E. Nature (London) 1993;361:156–159. doi: 10.1038/361156a0. [DOI] [PubMed] [Google Scholar]
- 15.Cooper H M, Herbin M, Nevo E. J Comp Neurol. 1993;328:313–350. doi: 10.1002/cne.903280302. [DOI] [PubMed] [Google Scholar]
- 16.Janssen J W H, Bovee-Geurts P H M, Peeters Z P A, Bowmaker J K, Cooper H M, David-Gray Z K, Nevo E, DeGrip W J. J Biol Chem. 2000;275:38674–38679. doi: 10.1074/jbc.M008254200. [DOI] [PubMed] [Google Scholar]
- 17.David-Gray Z K, Janssen J W H, Nevo E, Foster R G. Nat Neurosci. 1998;12:655–656. doi: 10.1038/3656. [DOI] [PubMed] [Google Scholar]
- 18.David-Gray Z K, Cooper H M, Jenssen J W H, Nevo E, Foster R G. FEBS Lett. 1999;461:343–347. doi: 10.1016/s0014-5793(99)01455-6. [DOI] [PubMed] [Google Scholar]
- 19.Ben-Shlomo R, Ritte U, Nevo E. Behav Genet. 1995;25:239–245. doi: 10.1007/BF02197182. [DOI] [PubMed] [Google Scholar]
- 20.Nevo E, Guttman R, Haber M, Erez E. J Mammal. 1982;63:453–463. [Google Scholar]
- 21.Tobler I, Nevo E, Hermann M. Behav Brain Res. 1998;96:173–183. doi: 10.1016/s0166-4328(98)00012-6. [DOI] [PubMed] [Google Scholar]
- 22.Goldman B D, Goldman S L, Riccio A P, Terkel J. J Biol Rhythms. 1997;12:348–361. doi: 10.1177/074873049701200407. [DOI] [PubMed] [Google Scholar]
- 23.Dunlap J C. Cell. 1999;96:271–290. doi: 10.1016/s0092-8674(00)80566-8. [DOI] [PubMed] [Google Scholar]
- 24.Kyriacou C P. Behav Genet. 1990;20:191–211. doi: 10.1007/BF01067790. [DOI] [PubMed] [Google Scholar]
- 25.Hogenesch J B, Gu Y Z, Jain S, Bradfield C A. Proc Natl Acad Sci USA. 1998;95:5474–5479. doi: 10.1073/pnas.95.10.5474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bunger M K, Wilsbacher L D, Moran S M, Clendenin C, Radcliffe L A, Hogenesch J B, Simon M C, Takahashi J S, Bradfield C A. Cell. 2000;103:1009–1017. doi: 10.1016/s0092-8674(00)00205-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Shearman L P, Sriram S, Weaver D R, Maywood E S, Chaves I, Zheng B, Kume K, Lee C C, van der Horst G T, Hastings M H, Reppert S M. Science. 2000;288:1013–1019. doi: 10.1126/science.288.5468.1013. [DOI] [PubMed] [Google Scholar]
- 28.Veres G, Gibbs R A, Scherer S E, Caskey C T. Science. 1987;237:415–417. doi: 10.1126/science.3603027. [DOI] [PubMed] [Google Scholar]
- 29.Kimura M. The Neutral Theory of Molecular Evolution. Cambridge, U.K.: Cambridge Univ. Press; 1983. [Google Scholar]
- 30.Weir B S. Genetic Data Analysis II. Sunderland, MA: Sinauer Associates; 1996. p. 356. [Google Scholar]
- 31.Albrecht U, Sun Z, Eichele G, Lee C. Cell. 1997;91:1055–1064. doi: 10.1016/s0092-8674(00)80495-x. [DOI] [PubMed] [Google Scholar]
- 32.Abe H, Honma S, Namihira M, Takahasi Y, Ikeda M, Yu W, Honma K. Brain Res Mol Brain Res. 1999;20:104–110. doi: 10.1016/s0169-328x(99)00031-5. [DOI] [PubMed] [Google Scholar]
- 33.Schopfer R, Figueroa F, Nizetic D, Nevo E, Klein J. Mol Biol Evol. 1987;4:287–299. doi: 10.1093/oxfordjournals.molbev.a040439. [DOI] [PubMed] [Google Scholar]
- 34.Avivi A, Resnick M B, Nevo E, Joel A, Levy A P. FEBS Lett. 1999;452:133–140. doi: 10.1016/s0014-5793(99)00584-0. [DOI] [PubMed] [Google Scholar]
- 35.Nevo E, Filippucci M G, Beiles A. Heredity. 1994;72:465–487. doi: 10.1038/hdy.1994.65. [DOI] [PubMed] [Google Scholar]
- 36.Nevo E, Honeycutt R L, Yonekawa H, Nelson K, Hanzawa N. Mol Biol Evol. 1993;10:590–604. doi: 10.1093/oxfordjournals.molbev.a040026. [DOI] [PubMed] [Google Scholar]
- 37.Nevo E, Beiles A. Biol J Linn Soc. 1992;47:385–405. [Google Scholar]
- 38.Catzeflis F M, Nevo E, Ahlquist J E, Sibley C G. J Mol Evol. 1989;29:223–232. doi: 10.1007/BF02100206. [DOI] [PubMed] [Google Scholar]
- 39.Nevo E, Beiles A, Spradling T. J Mol Evol. 1999;49:215–226. doi: 10.1007/pl00006544. [DOI] [PubMed] [Google Scholar]
- 40.Nevo E, Tchernov E, Beiles A. Z Zool Syst Evol Forsch. 1988;26:286–314. [Google Scholar]
- 41.Kay S A. Science. 1997;276:753–754. doi: 10.1126/science.276.5313.753. [DOI] [PubMed] [Google Scholar]
- 42.Gu Y Z, Hogenesch J, Bradfield C. Annu Rev Pharmacol Toxicol. 2000;40:519–561. doi: 10.1146/annurev.pharmtox.40.1.519. [DOI] [PubMed] [Google Scholar]
- 43.Mitchell P J, Tjian R. Science. 1989;245:371–378. doi: 10.1126/science.2667136. [DOI] [PubMed] [Google Scholar]
- 44.Antoch M P, Song E J, Chang A M, Vitaterna M H, Zhao Y, Wilsbacher L D, Sangoram A M, King D P, Pinto L H, Takahashi J S. Cell. 1997;89:656–667. doi: 10.1016/s0092-8674(00)80246-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.King D P, Zhao Y, Sangoram A M, Wilsbacher L D, Tanaka M, Antoch M P, Steeves T D, Vitaterna M H, Kornhauser J M, Lowrey P L, et al. Cell. 1997;89:641–653. doi: 10.1016/s0092-8674(00)80245-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Gekakis N, Stakins D, Nguyen H B, Davis H B, Wilsbacher L D, King D P, Takahashi J S, Weitz C J. Science. 1998;280:1564–1569. doi: 10.1126/science.280.5369.1564. [DOI] [PubMed] [Google Scholar]
- 47.Darlington T K, Wager-Smith K, Ceriani M F, Staqnis D, Gekakis N, Steeves T D L, Weitz C J, Takahashi J S, Kay S A. Science. 1998;280:1599–1603. doi: 10.1126/science.280.5369.1599. [DOI] [PubMed] [Google Scholar]
- 48.Kyriacou C P, Hall J C. Proc Natl Acad Sci USA. 1980;77:6929–6933. [Google Scholar]
- 49.Yamazaki S, Numano R, Abe M, Hida A, Takahashi R, Ueda M, Block G D, Sakaki Y, Menaker M, Tei H. Science. 2000;288:682–685. doi: 10.1126/science.288.5466.682. [DOI] [PubMed] [Google Scholar]
- 50.Argamaso S M, Froehlich A C, McCall M A, Nevo E, Provencio I, Foster R G. Biophys Chem. 1995;56:3–11. doi: 10.1016/0301-4622(95)00009-m. [DOI] [PubMed] [Google Scholar]
- 51.Balemans M G M, Pevet P, Legerstee W C, Nevo E. J Neural Transm. 1980;49:247–255. doi: 10.1007/BF01252129. [DOI] [PubMed] [Google Scholar]
- 52.Rehkamper G, Necker R, Nevo E. J Comp Neurol. 1994;347:570–584. doi: 10.1002/cne.903470408. [DOI] [PubMed] [Google Scholar]